Acro Pharmaceutical Services to dispense Esbriet® (pirfenidone) for treatment of Idiopathic Pulmonary Fibrosis (IPF)
January 19, 2016
Sharon Hill, PA
Acro Pharmaceutical Services (“Acro”) has been selected by Genentech as part of a limited specialty pharmacy network for Esbriet® (pirfenidone) for patients throughout the United States. Acro is now accepting prescriptions for Esbriet®, which has been approved by the U.S Food and Drug Administration as a treatment for idiopathic pulmonary fibrosis (IPF).
Idiopathic pulmonary fibrosis is a chronic lung disease that causes scarring of the lung tissue. The progressive disease causes shortness of breath, coughing, and decreased ability to participate in daily activity. Clinical trials have shown Esbriet® to slow down the decline of lung function in patients with idiopathic pulmonary fibrosis (IPF).
Acro’s specialty pharmacy services, in addition to medication dispensing, offers patient support for the enrollment into Genentech’s Access Solutions program for Esbriet®. This patient support program provides assistance with benefits and coverage issues, reimbursement guidance and product distribution. The program can be found at www.Genentech-Access.com/Esbriet.
Acro is owned by Lincare Inc., a subsidiary of The Linde Group. All specialty pharmacy services and support are provided by Acro’s pharmacy headquarters in Sharon Hill, Pennsylvania (near Philadelphia) and its satellite location in Memphis, Tennessee, to serve patients and providers for key insurance plans and PBMS nationwide.
Lincare has long been known as a leader in respiratory care and provides a variety of respiratory support services. Lincare has over 850 locations in 48 states and is able to service each patient, whether they are right down the street or across the country.
Acro Pharmaceutical Services (Acro) dispenses specialty medications directly to physician offices and to patients’ homes throughout the United States. Acro Pharmaceutical Services offers online pharmacy services such as prescription refills, prior authorization forms, and other services to assist the patient and provider. These specialty medications often focus on, but are not limited to, specific disease states such as Pulmonary Fibrosis and other Pulmonary diseases, Multiple Sclerosis, Psoriasis, Rheumatoid Arthritis, Growth Hormone Deficiency, blood clotting disorders, Cancer, Addiction Treatment, Mental Health Disorders, Gastrointestinal Diseases, Rare Orphan Diseases and many others.
To obtain a prescription referral form, please visit our website at opioidcrisis.wpengine.com/web/providers_pdf_forms or contact an Acro representative at (800) 906-7798.